This is your liver. Overview. Functions of the Liver 3/9/2015. This is your liver on Drugs. Drugs and the Liver Drug Induced Liver Injury (DILI)

Similar documents
EVALUATION OF ABNORMAL LIVER TESTS

Diagnostic evaluation of suspected Drug-Induced Liver Injury

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

Drug-induced liver injury

Herbal Supplements and the Liver. Lauren Myers PA-C, MMsc

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS

Approach to the Patient with Liver Disease

Drug Induced Liver Disease Role of the Pathologist. Disclosure. DILI can never be excluded. Romil Saxena, MD. Dr. Saxena has nothing to Disclose

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Drug Induced Liver Injury (DILI)

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

Patterns of abnormal LFTs and their differential diagnosis

Interpreting Liver Function Tests

Liver Disease That Presents with Jaundice (PBC, Alcohol and Drugs): Diagnosis and Patient Management. Emma Pham, PA-C

Serologic Markers CONVENTIONAL ANTIBODIES ANTIBODIES UNCONVENTIONAL. AIH Type I

Drug Induced Liver Injury. Case. Case 8/8/2016. Donald Gardenier, DNP, FNP BC, FAAN, FAANP Desert Oasis Health Care Palm Springs, CA

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Patterns of abnormal LFTs and their differential diagnosis

Approach to Abnormal Liver Tests

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

HEPETIC SYSTEMS BIOCHEMICAL HEPATOCYTIC SYSTEM HEPATOBILIARY SYSTEM RETICULOENDOTHELIAL SYSTEM

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Disclosures Drug-induced Acute Liver Failure

VIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Acute Hepatitis: An Approach to Infectious and Other Causes. Mary Anne Cooper MSc, MD, MEd, FRCPC

A Rational Evidence-based Approach to Abnormal Liver Tests

1. Based on A.S. s labs and presentation, what type of liver injury would you classify her as experiencing?

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

British Liver Transplant Group Pathology meeting September Leeds cases

Disclosure. Evaluation of Abnormal Hepatic Enzymes

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

Key Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT

Suspected Isoflurane Induced Hepatitis from Cross Sensitivity in a Post Transplant for Fulminant Hepatitis from Halothane.

Therapies for DILI: NAC, Steroids or NRF-2 activators?

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014

DILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting

TB Case Management Hepatitis

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya

Intrinsic vs. Idiosyncratic DILI

-Liver function tests -

Basic Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics

Autoimmune Hepatitis. Dr. Stefania Casu Hepatology, UVCM, Inselspital Bern. November 14th, 2018

Drug therapy in patient with hepatic impairment

Drug Induced Liver Injury: A Clinical Perspective. Robert J. Fontana, MD

Extrahepatic Biliary Obstruction. Ductal Diseases: Stones Tumors. Acute Injury: Viral Hepatitis Toxin (APAP/Etoh) Reye s Shock.

July Hepatitis Monthly Awareness Toolkit

Chapter 143 Acetaminophen

Alpha-1 Liver Disease

So, this is a group of patients that were treated with an anti-inflammatory drug in development within Eli Lilly. The name of the compound was an

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006

LIVER SPECIALTY CONFERENCE USCAP Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA

DRUG INDUCED LIVER INJURY DIPENDRA PARAJULI 02/02/2006. University of Louisville

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

Autoimmune hepatitis

Acute Liver Failure. Agenda. Natalie H Bzowej, MD, PhD, FRCPC. Case Introduction Definition Diagnosis Initial Laboratory Evaluation Acetaminophen NAC

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK

Chronic Hepatic Disease

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

Clinical Dilemmas in Liver Disease

Biochemistry Liver Function Tests (LFTs)

Liver Cancer Causes, Risk Factors, and Prevention

Approach to the Patient with Abnormal Liver Enzymes

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease

World Health Organization. Western Pacific Region

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology

Paul Martin, MD, FACG. University of Miami. 30,000 deaths from cirrhosis per annum, alcohol implicated in 48%

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy

Spring 2017 Health & Wellness Seminar Series. Seminar 1: April 25 th, 2017

Table 1 Some of the drugs that induce DILI and the mechanisms underlying their toxicity

Drug-, herb- and dietary supplement-induced liver injury

Pittsburgh CME Conference November 7-9, 2014

Liver Disease. By: Michael Martins

Drug-Induced Liver Injury

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

AASLD Immune tolerant phase HBV NAFLD diagnostic HCC

Primary Sclerosing Cholangitis Medical Management

SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets

Autoimmune Hepatitis in Clinical Practice

Management of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran

Recent Status of Drug-induced Liver Injury and Its Problems in Japan

Primary Biliary Cholangitis

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and

Anaemia Pathway. Anaemia. Type of Anaemia Check Haematinics (Iron stores,b12,folate) Fit for endoscopies. endoscopies yes no. Non Iron Deficient

Chronic Liver Disease after Acute Hepatocellular DILI

NON-ALCOHOLIC FATTY LIVER DISEASE:

Should There Be a Standard of Care (SOC) for Drug-Induced Liver Injury (DILI)? Leonard B Seeff, MD

CrackCast Episode 28 Jaundice

Hepatitis C Information Sheet.

Doc, is it good for my liver?

Chapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued)

Liver Function Tests. Dr. Abdulhussien Aljebory Babylon university College of Pharmacy

Transcription:

This is your liver Drugs and the Liver Drug Induced Liver Injury (DILI) Rebecca Duke DNP, MSN, APN-CNP AACN Spring 2015 Transplant Surgery Nurse Practitioner This is your liver on Drugs Overview Over 1000 medications and herbal products have been implicated in DILI 30% of cases of acute hepatitis Cause of jaundice in 50% of patients with new onset jaundice Most common reason for withdrawal of medications The metabolites of compounds are usually the causative factors of DILI Functions of the Liver Liver injury may be produced by a large variety of chemical substances Secretory 1) Bile acid from cholesterol 2)Conjugation of bili Excretory Excretion of exogenous dyes/substa nces Metabolic 1) CHO 2) Lipid 3) Ammonia acid 4) Cholesterol synthesis 5) Mineral 6) Ammonia formation 7) Vitamin 8) Nucleic acid 9) Interconversion of sugars Synthetic Synthesis of 1) Albumin 2) Alpha 1 Gamma globulins 3) Clotting factors 4) Binding proteins 5) Transport Proteins 6) Hormones 7) Cholesterol Detoxification of 1) Xenobiotics 2) Steroids 3) Thyroid hormone 4)Endogenous metabolit es Storage 1) Glycogen 2) B12 3) Vitamin A 4) Copper 5) Iron The type and degree of injury produced is extremely varied, and may mimic the entire spectrum of hepatobiliary disorders The central role played by the liver in the clearance and biotrasnformation of chemicals make the liver susceptible to drug-induced injury. Drugs can initiate progressive chronic liver disease and are the single leading cause of acute liver failure. 1

Overview Definitions Type of injury Prescription medications Over the counter Complementary Alternative Medicine (CAM) Illicits Drugs and Disease Drugs in the cirrhotic liver Classification of DILI (drug induced liver injury) Clinical presentation Hepatocellular (cytotoxic) injury Cholestatic injury Mixed injury Mechanisms of hepatotoxicity Intrinsic/Predictable - Tylenol Idiosyncratic only if genetic variable are right Histologic findings Hepatitis Cholestasis Steatosis Hepatocellular Injury AST/ALT elevated Little to no elevation of Alk Phos Ratio helpful ETOH AST:ALT 2:1 Viral hepatitis AST:ALT <1 Common Causes NAFLD/NASH DILI ETOH Hemochromatosis Viral Hepatitis Extrahepatic conditions Cholestatic Injury Lab abnormalities: Alkaline phosphatase, GGT, Total bilirubin elevated Common etiologies Biliary diseases PBC, PSC DILI ETOH hepatitis Hormonal effects on bile flow during pregnancy (cholestasis of pregnancy) Cancer HBV or HCV Cirrhosis (not as common until significant severity) Bile stone/stricture Pancreatic cancer Pharmacology and the Liver Cytochrome P450 system Most drugs are metabolized in the liver Cytochrome P450 system Drug induced pattern Cholestatic, hepatocellular Can cause steatosis Major enzymes involved in drug and bio-activation Inducers and inhibitors Inducers- induces the enzyme Less drug in system Inhibitors inhibits the enzyme More drug in system 2

Variables in People for Idiosyncratic DILI Host Factors Environmental Factors Drug-Related Factors Age Smoking Daily Dose Gender Alcohol consumption Metabolic profile Pregnancy Malnutrition Obesity Diabetes Mellitus Co-morbidities including underlying liver disease Indications for therapy Genetics Renal Function Infection and inflammatory episodes Class effect and cross sensitization Drug interactions and polypharmacy Duration of therapy Evaluation of Suspected Idiosyncratic Drug Reactions Hepatitis A, B, C >2 or <5 (mixed) Viral Hepatitis, Autoimmune hepatitis, imaging Abnormal LFTs Thorough H&P Calculate R value >/=5 Hepatocellular Viral Hepatitis, autoimmune hepatitis, imaging </=2 (Cholestatic) Imaging Studies Autoimmune markers: ANA, AMA, SMA Detective Work.Let s put on the hat History is critical Medication history back 2-3 months How long as lab abnormality been noted? How long as jaundice been present Any dark urine? Have they ever been on this medication before? Have they ever had a drug reaction/sensitivity previously? Drugs in same class?? Over the Counters (OTC s) Over the Counter Drugs NSAIDs Acetaminophen Iron supplements Vitamins NSAIDs Those with cirrhosis or advanced liver disease should avoid this class of drugs Hepatitis can occur with variable rates among NSAIDs Diclofenac more common Hepatitis usually resolves after stopping the drug Rare reports of liver failure and chronic liver disease Hepatorenal syndrome Type 1 or type 2 cause renal dysfunction and even renal failure Most common in those with significant hepatic dysfunction/decompensation Block prostaglandins which help with vasodilation Can cause renal problems 3

Acetaminophen Okay in liver disease Preferred over NSAIDs No > than 1000 mg/dose No > than 3000 mg/day (FDA says 4000) Conservative dosing recommended no > 2000 mg/day > 3 alcoholic beverages no more than 2000 mg/day Acetaminophen Injury can occur with single dose of 7-10 grams More likely with ingested dosages > 150 mg/kg Children are lower Most recover with supportive measures Need for transplantation Rising INR poor prognostic factor 5% children Therapeutic misadventure More common in elderly, polypharmacy or with OTC combination therapies (cold/uri medication) Iron Supplements Vitamins Hemochromatosis Increased risk for HCC Secondary disease may become exacerbated Those with cirrhosis Overload can cause progression No supplementation unless has IDA Be careful of vitamins with extra iron, prenatal vitamins Vitamin A high doses can be toxic to the liver mild and reversible elevated LFT s Rare liver failure Pre-existing and alcohol = worse Improve with d/c If vitamin deficient Replete and repeat Background In 2004 18.9% of U.S. adults reported using natural products Complementary and Alternative Medications (CAM).Herbals etc. Dietary Supplement Health and Education Act (DSHEA) and Final Rule for Dietary Supplement Current Good Manufacturing Practices Does not focus on safety of the ingredients Contains no minimum requirements for quality No responsibility for safety surveillance or reporting to manufacturer 4

CAM therapy Reports of acute hepatitis, veno-occlusive disease, fulminant hepatic failure, cirrhosis Interactions more common Not well studied (Traditional FDA trials) Valerian Complementary Alternative Medicine (CAM) Therapies..Not exhaustive in this lecture Black Cohosh Milk Thistle or silymarin Kava Glycyrrhizin (licorice root extract) Diet drugs Hydroxycut, herbalife, Ma Huang liver cleanse Valerian Perennial plant native to Europe Used to treat anxiety, insomnia and nervous restlessness Increases GABA in the brain?? Study found to be no more effective than placebo (14 days) Other studies showed that it can reduce time to fall asleep and improves quality of sleep May effect of drugs in the liver cause toxic levels Statins, antifungal drugs Increase effects of anticonvulsants, barbituates, benzdiazepines, insomnia meds, TCA s and alcohol May effect anesthesia Slows down CNS Black Cohosh Derived from a plant native to N. America Used to treat menopausal symptoms, joint pain, myalgia, bronchitis and obesity Hepatotocixity ranges from autoimmunelike hepatitis to ALF Milk Thistle/Silymarin Anti-oxidant and free-radical scavenger Most commonly utilized for patients in liver disease Thought to have anti-fibrotic activity No side effects Evidence variable Not likely to improve ALT levels JAMA, 2012 Stickel F, Schuppan D. Herbal Medicine in the treatment of liver diseases. Digestive and Liver Disease. 39 (2007) 293-304. 5

Kava Glycyrrhizin (licorice root extract) Kava root psychotropic remedy in Hawaii, polynesia and the Fiji islands Europe and elsewhere Anxiety disorders Hepatic necrosis or cholestatic hepatitis Can develop fulminant liver failure necessitating liver tx Patients ingesting greater than 250 mg a day of kavalactones are at increased risk Prevents liver injury in animals Anti-oxidant activity Blunts ALT elevations and impedes fibrosis in animals Reported to be beneficial in viral hepatitis Can improve AST/ALT in NAFLD/NASH Single study Comprehensive studies needed Hajiaghamohammadi, A. A., Ziaee, A. and Samimi, R. (2012), The Efficacy of Licorice Root Extract in Decreasing Transaminase Activities in Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Phytother. Res., 26: 1381 1384. doi: 10.1002/ptr.3728 Diet Drugs Herbalife & Hydroxycut Several case reports of acute liver injury Exact mechanism unknown Necrosis and cholestasis on biopsy Idiosyncratic reaction possible Allergic reaction? Contamination? Hydroxycut 3/8 patients required transplantation No studies done Does not require FDA approval Only case studies Ma Huang ephedra - banned Stickel F, Schuppan D. Herbal Medicine in the treatment of liver diseases. Digestive and Liver Disease. 39 (2007) 293-304. Chen GC, Ramanathan VS, Law D, Funchain P, Chen GC, French S, Shlopov B, Eysselein V, Reicher S, Pham BV. World J Hepatol. 2010 November 27; 2(11) 410-415; Am J Gastroenterol 2010;105:1561 1566; doi:10.1038/ajg.2010.5; published online 26 January 2010 Green Tea Extract Dandelion Natural diuretic Stimulates bile flow No evidence for improvement in the liver Used in combo products No proven studies 6

Liver Cleanse/Combo CAM Usually combination medications Usually milk thistle Dandelion Other extracts such as artichoke, tumeric etc. Prescription Medications Antibiotics Most reactions are idiosyncratic Tetracyclines and oxypenicillins Usually dose related Erythromycin induced injury usually improves after d/c Sulfamethoxazole Trimethoprim Ampicillin, amoxicillin and Augmentin (amox/clav) Cholestatic and mixed hepatocellular injury Onset of jaundice may be delayed reaction (can happen months after cessation) (Amox/Clav) More Antibiotics Sulfonamides Cholestasis Less common granulomatous hepatitis Hepatocellular necrosis fatal cases Nitrofurantoin Acute and chronic hepatic injury May be immunoallergic or metabolic Fluoroquinolones Macrolides Minocycline Antifungals More common in immunocompromised or on multiple meds Nitrofurantoin Hepatitis Fatigue Fever Muscle and joint aches Poor appetite Nausea/vomiting Weight loss Jaundice Methotrexate At risk populations: Obese Pre-existing liver disease Alcohol Use lower doses Monitor LFT s closely May need to biopsy prior to start of therapy Biopsy may be warranted if half of the monitored LFT s are elevated in one year period Surveillance biopsy after on therapy for a few years 7

Tuberculosis Medications Isoniazid 0.1-0.3% - symptomatic 10-20% elevation of transaminases Histopathology resembles viral hepatitis Resolves 1-4 weeks after d/c Worse with alcohol or concomitant use of acetaminophen or rifampin Rifampin P450 system 1.1% rate of liver toxicity Worse with HCV, HBV, alcoholism Cholestasis, jaundice Tbili up to 30 or more Resolves after d/c Cholestatic injury can take weeks or longer to recover/resolve Statins 0.5-3% have elevated LFT s Can be utilized in those with liver disease CV disease will kill many patients before a mild elevation in their enzymes does anything Monitor LFT s Prior to start of Rx 2-3 months Every 6 months Niacin Anti-Convulsants Can cause mild transaminitis, jaundice and in rare cases liver failure Liver toxicity is dose dependent Toxic doses usually exceed 2 grams per day Worse in those with pre-existing liver disease and alcohol Phenytoin hepatocellular damage rare CYP450 inducer Carbamazepine/Oxcarbazepine liver failure can occur despite d/c Lamotrigine liver failure has been reported in both peds and adults Phenobarbital Valproic acid 20% of patients have elevated LFT s Liver failure more common in children Amiodarone Hydralazine Liver injury ranging from mild transaminase elevations to acute liver failure and cirrhosis Abnormalities usually resolve weeksmonths after stopping meds Significant damage can occur < 1% of patients Used to treat HTN Hepatotoxicity Hypersensitivity-type injury Mixed hepatocellular injury Acute hepatitis Cholestatic jaundice Centrilobular necrosis Reversible after d/c the med 8

Illicit Drugs Amphetamines Ecstasy can cause liver failure in severe cases Cocaine ischemic necrosis of the liver Drugs and the Cirrhotic Liver Liver dysfunction causes alterations in clearance May need to adjust dosage Start slow Statins lower doses and monitor LFT s Check enzymes more frequently Anabolic Steroids Not illicit to utilized without indication TPN Drugs and Fatty Liver Disease Methotrexate Tamoxifen Steroids Valprate Amiodarone Questions? Thank you! rduke@nm.org HAART therapy 9